Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.620
-0.050 (-2.99%)
At close: Jul 14, 2026, 4:00 PM EDT
1.500
-0.120 (-7.41%)
After-hours: Jul 14, 2026, 7:41 PM EDT
Pulmatrix Earnings Call Transcripts
Fiscal Year 2024
-
Pulmatrix and Cullgen will merge, with Cullgen stockholders owning 96.4% of the combined entity, which will operate under the Cullgen name and focus on targeted protein degraders and DACs. The merger, expected to close by March 2025, brings $65M in cash and a robust clinical pipeline.